您的购物车当前为空
DC-BPi-03 是一种新型 BPTF-BRD 抑制剂(IC50 为 698.3 nM),具有潜在的抗癌户型,可用于研究白血病。


为众多的药物研发团队赋能,
让新药发现更简单!
DC-BPi-03 是一种新型 BPTF-BRD 抑制剂(IC50 为 698.3 nM),具有潜在的抗癌户型,可用于研究白血病。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 253 | In Stock | |
| 5 mg | ¥ 589 | In Stock | |
| 10 mg | ¥ 957 | In Stock | |
| 25 mg | ¥ 1,890 | In Stock | |
| 50 mg | ¥ 2,970 | In Stock | |
| 100 mg | ¥ 4,930 | In Stock | |
| 200 mg | ¥ 6,830 | In Stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 648 | In Stock |
DC-BPi-03 相关产品
| 产品描述 | DC-BPi-03 is a novel BPTF-BRD inhibitor (IC50 of 698.3 nM) with a potential anticancer phenotype for leukemia research. |
| 分子量 | 302.35 |
| 分子式 | C14H14N4O2S |
| CAS No. | 2758411-46-8 |
| Smiles | O=S(=O)(C=1N=C(C=C(N1)C2=CC=C3NC=CC3=C2)NC)C |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | ||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 20 mg/mL (66.15 mM), Sonication is recommended. | ||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2.5 mg/mL (8.27 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | ||||||||||||||||||||||||||||||
溶液配制表 | |||||||||||||||||||||||||||||||
DMSO
| |||||||||||||||||||||||||||||||
评论内容